ACRV

ACRIVON THERAPEUTICS INC

ACRV·004890109·US·Common Stock·Healthcare - Biotechnology-Activist

ACRV (ACRIVON THERAPEUTICS INC) is held by 33 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($21.8M), VANGUARD CAPITAL MANAGEMENT LLC ($1.7M), WELLINGTON MANAGEMENT GROUP LLP ($1.6M). Net institutional sentiment: Mixed.

33
Holders
(2 Elite)
$30.8M
Total Value
62% (29)
Consensus
18 buying - 11 selling
13F: Insider & Congress: Updated regularly
ACRV

Smart Money Verdict

View all
Loading verdict
Held by 33 funds
2 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Aug 27, 2026 · Activists Aug 13, 2026 · Congress none

InsiderBPBlume-Jensen PeterSell $31KAug 25, 2026
InsiderBPBlume-Jensen PeterSell $972.84Aug 18, 2026
InsiderPKPeterson KatharineSell $203.01Aug 18, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12.2M(+46.6%)$21.8M0.2%-69.58%
46
Increased
952,008(+31.9%)$1.7M0.0%+21.42%
22
Unchanged
888,130$1.6M0.0%-82.12%
0
Increased
758,863(+0.1%)$1.4M0.0%+16.31%
25
Increased
641,498(+64.7%)$1.1M0.0%+10.82%
37
Decreased
531,856(-5.1%)$946,7040.0%-51.08%
0
Increased
265,241(+12.2%)$472,2730.0%-71.70%
18
Increased
239,112(+14.4%)$425,6200.0%-57.89%
19
Increased
184,128(+71.2%)$327,7480.0%+20.06%
35
Increased
178,239(+166.5%)$317,2650.0%+22.29%
38
Decreased
74,648(-68.9%)$132,8740.0%+48.04%
0
Increased
67,202(+37.4%)$119,6200.0%-66.31%
20
Unchanged
67,145$119,5180.0%-62.94%
0
Increased
43,850(+26.6%)$78,0530.0%+13.57%
18
New
41,276$73,4710.0%+15.73%
32
Increased
29,332(+59.7%)$52,2120.0%-52.15%
20
Decreased
16,407(-0.6%)$29,2040.0%-61.92%
0
Increased
14,920(+1.2%)$26,5580.0%-17.99%
13
Decreased
13,309(-51.5%)$23,6900.0%+68.52%
0
Decreased
10,000(-50.0%)$17,8000.0%+0.24%
0

Showing 1-20 of 36

1 / 2
ACRVACRVACRIVON THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used